Background Progesterone prepares the endometrium for pregnancy by stimulating
proliferation in response to human chorionic gonadotropin (hCG), which is produced by the …

Background Miscarriage, defined as the spontaneous loss of a pregnancy before 24 weeks'
gestation, is common with approximately 25% of women experiencing a miscarriage in their …

STUDY QUESTION Is oral dydrogesterone 30 mg daily (10 mg three times daily [TID]) non-
inferior to micronized vaginal progesterone (MVP) 600 mg daily (200 mg TID) for luteal …

With significant improvements in cryopreservation technology (vitrification) the number of
frozen ET IVF cycles is increasing and may soon surpass in numbers and success rates …

STUDY QUESTION Is oral dydrogesterone 30 mg daily non-inferior to 8% micronized
vaginal progesterone (MVP) gel 90 mg daily for luteal phase support in IVF? SUMMARY …

The aim of this systematic review and meta-analysis was to conduct a comprehensive
assessment of the evidence on the efficacy and safety of oral dydrogesterone versus …

The pharmacological and physiological profiles of progestogens used for luteal phase
support during assisted reproductive technology are likely to be important in guiding clinical …

Progesterone is a steroid hormone of essential role in reproduction. In early pregnancy, it is
responsible for preparation of endometrium for implantation process and maintenance of …

Successful oocyte implantation and a favorable pregnancy outcome rely on optimal
progesterone levels. Therefore, progesterone deficiencies associated with infertility and …

Objectives To compare the effects of dydrogesterone and progesterone for luteal‐phase
support (LPS) in women undergoing assisted reproductive techniques (ART). Methods We …